Skip to main content
What types of page to search?

Alternatively use our A-Z index.

Vijay Sharma

Dr Vijay Sharma
BScHons MBChB PhD FRCPath FRSB MAcadMEd

Course Lead, Pathology; Clinical Director, Cellular Pathology; Consultant Histopathologist; Honorary Senior Lecturer
School of Medicine

Publications

What type of publication do you want to show?

2024

Abstract B012: Understanding the role of VISTA in regulating T cell function and the therapeutic potential of blocking VISTA in triple negative breast cancer

Abudula, M., Astuti, Y., Raymant, M. R., Sharma, V., Schmid, M., & Mielgo, A. (2024). Abstract B012: Understanding the role of VISTA in regulating T cell function and the therapeutic potential of blocking VISTA in triple negative breast cancer. Cancer Research, 84(22_Supplement), B012. doi:10.1158/1538-7445.tumbody-b012

DOI
10.1158/1538-7445.tumbody-b012
Journal article

Morphological and molecular changes of oestrogen receptor-positive breast cancer following bridging endocrine therapy: a United Kingdom multicentre study.

Miligy, I. M., Awasthi, R., Mir, Y., Khurana, A., Sharma, V., Chandaran, U., . . . Shaaban, A. M. (2024). Morphological and molecular changes of oestrogen receptor-positive breast cancer following bridging endocrine therapy: a United Kingdom multicentre study.. Histopathology, 85(3), 405-417. doi:10.1111/his.15238

DOI
10.1111/his.15238
Journal article

A Bioinformatic Characterisation of the Glyolytic Enzyme ENO1 as a Biomarker of Breast Cancer Progression

DOI
10.21203/rs.3.rs-3853453/v1
Preprint

2023

ENO1 as a biomarker of breast cancer progression and metastasis – a bioinformatic approach

DOI
10.1101/2023.11.01.23297919
Preprint

2022

Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression

Giannoudis, A., Vareslija, D., Sharma, V., Zakaria, R., Platt-Higgins, A., Rudland, P. S., . . . Palmieri, C. (2022). Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression. ESMO OPEN, 7(6). doi:10.1016/j.esmoop.2022.100636

DOI
10.1016/j.esmoop.2022.100636
Journal article

Control of Fatty Acid Oxidation by the Sympathetic Nervous System in the Diabetic Heart: Implications for Both Heart Failure and Cancer

Sharma, V., & McNeill, J. H. (2022). Control of Fatty Acid Oxidation by the Sympathetic Nervous System in the Diabetic Heart: Implications for Both Heart Failure and Cancer. In R. W. Sowadogo (Ed.), Current Innovations in Medicine and Medical Science Volume 2 (pp. 1-20). B P International.

Chapter

The importance of ARG2 expression in the immune-depleted microenvironment of primary breast cancer and brain metastasis

Giannoudis, A., Vareslija, D., Sharma, V., Zakaria, R., Platt-Higgins, A., Rudland, P., . . . Palmieri, C. (2022). The importance of ARG2 expression in the immune-depleted microenvironment of primary breast cancer and brain metastasis. In ANNALS OF ONCOLOGY Vol. 33 (pp. S132). doi:10.1016/j.annonc.2022.03.035

DOI
10.1016/j.annonc.2022.03.035
Conference Paper

2016

The Application of Chaos Theory and Fractal Mathematics to the Study of Cancer Evolution: Placing Metabolism and Immunity Centre Stage

Sharma, V. (2016). The Application of Chaos Theory and Fractal Mathematics to the Study of Cancer Evolution: Placing Metabolism and Immunity Centre Stage. Medical Research Archives, 4(6). doi:10.18103/mra.v4i6.717

DOI
10.18103/mra.v4i6.717
Journal article

2015

2014

Combined metoprolol and ascorbic acid treatment prevents intrinsic damage to the heart during diabetic cardiomyopathy.

Saran, V., Sharma, V., Wambolt, R., Yuen, V. G., Allard, M., & McNeill, J. H. (2014). Combined metoprolol and ascorbic acid treatment prevents intrinsic damage to the heart during diabetic cardiomyopathy.. Canadian journal of physiology and pharmacology, 92(10), 827-837. doi:10.1139/cjpp-2014-0078

DOI
10.1139/cjpp-2014-0078
Journal article

Adrenergic Control of Cardiac Fatty Acid Oxidation in Diabetes

Sharma, V., & McNeill, J. H. (2014). Adrenergic Control of Cardiac Fatty Acid Oxidation in Diabetes. In Cardiac Energy Metabolism in Health and Disease (pp. 131-153). Springer New York. doi:10.1007/978-1-4939-1227-8_9

DOI
10.1007/978-1-4939-1227-8_9
Chapter

Metabolic and Contractile Remodelling in the Diabetic Heart: An Evolutionary Perspective

Sharma, V., & McNeill, J. H. (2014). Metabolic and Contractile Remodelling in the Diabetic Heart: An Evolutionary Perspective. In Diabetic Cardiomyopathy (pp. 27-40). Springer New York. doi:10.1007/978-1-4614-9317-4_2

DOI
10.1007/978-1-4614-9317-4_2
Chapter

2013

A new approach for measuring the work and quality of histopathology reporting.

Sharma, V., Davey, J. G. N., Humphreys, C., & Johnston, P. W. (2013). A new approach for measuring the work and quality of histopathology reporting.. Histopathology, 63(1), 130-136. doi:10.1111/his.12144

DOI
10.1111/his.12144
Journal article

Mortality in a teaching hospital during junior doctor changeover: a regional and national comparison.

Sharma, V., Proctor, I., & Winstanley, A. (2013). Mortality in a teaching hospital during junior doctor changeover: a regional and national comparison.. British journal of hospital medicine (London, England : 2005), 74(3), 167-169. doi:10.12968/hmed.2013.74.3.167

DOI
10.12968/hmed.2013.74.3.167
Journal article

2012

Does smoking kill? A study of death certification and smoking.

Proctor, I., Sharma, V., Khoshzaban, M., & Winstanley, A. (2012). Does smoking kill? A study of death certification and smoking.. Journal of clinical pathology, 65(2), 129-132. doi:10.1136/jclinpath-2011-200299

DOI
10.1136/jclinpath-2011-200299
Journal article

2011

Cardiac Dysfunction and Metabolism: Unravelling the Molecular Cross-Talk

Sharma, V., & McNeill, J. H. (2011). Cardiac Dysfunction and Metabolism: Unravelling the Molecular Cross-Talk. In Molecular Defects in Cardiovascular Disease (pp. 109-125). Springer New York. doi:10.1007/978-1-4419-7130-2_9

DOI
10.1007/978-1-4419-7130-2_9
Chapter

β-receptor antagonist treatment prevents activation of cell death signaling in the diabetic heart independent of its metabolic actions.

Sharma, V., Sharma, A., Saran, V., Bernatchez, P. N., Allard, M. F., & McNeill, J. H. (2011). β-receptor antagonist treatment prevents activation of cell death signaling in the diabetic heart independent of its metabolic actions.. European journal of pharmacology, 657(1-3), 117-125. doi:10.1016/j.ejphar.2011.01.044

DOI
10.1016/j.ejphar.2011.01.044
Journal article

2010

Functional effects of protein kinases and peroxynitrite on cardiac carnitine palmitoyltransferase-1 in isolated mitochondria.

Sharma, V., Abraham, T., So, A., Allard, M. F., & McNeill, J. H. (2010). Functional effects of protein kinases and peroxynitrite on cardiac carnitine palmitoyltransferase-1 in isolated mitochondria.. Molecular and cellular biochemistry, 337(1-2), 223-237. doi:10.1007/s11010-009-0303-2

DOI
10.1007/s11010-009-0303-2
Journal article

Modulation of Cardiac Metabolism by Beta‐Blockers During Diabetes: A Role in Apoptosis Signaling

Saran, V. V. V., Sharma, V., Yuen, V., Allard, M. F., & McNeill, J. H. (2010). Modulation of Cardiac Metabolism by Beta‐Blockers During Diabetes: A Role in Apoptosis Signaling. The FASEB Journal, 24(S1). doi:10.1096/fasebj.24.1_supplement.lb411

DOI
10.1096/fasebj.24.1_supplement.lb411
Journal article

2009

Stimulation of cardiac fatty acid oxidation by leptin is mediated by a nitric oxide-p38 MAPK-dependent mechanism.

Sharma, V., Sharma, V., Mustafa, S., Patel, N., Wambolt, R., Allard, M. F., & McNeill, J. H. (2009). Stimulation of cardiac fatty acid oxidation by leptin is mediated by a nitric oxide-p38 MAPK-dependent mechanism.. European journal of pharmacology, 617(1-3), 113-117. doi:10.1016/j.ejphar.2009.06.037

DOI
10.1016/j.ejphar.2009.06.037
Journal article

Insulin resistance and endothelial dysfunction: Are epoxyeicosatrienoic acids the link?

Sharma, V., Mustafa, S., & McNeill, J. H. (2009). Insulin resistance and endothelial dysfunction: Are epoxyeicosatrienoic acids the link?. Experimental and Clinical Cardiology.

Journal article

Metabolic and structural remodeling of heart‐derived H9c2 cells by AMPK activation

Dai, J. M., Saeedi, R., Sharma, V., Saran, V., Parsons, H., Dyck, J., & Allard, M. (2009). Metabolic and structural remodeling of heart‐derived H9c2 cells by AMPK activation. The FASEB Journal, 23(S1). doi:10.1096/fasebj.23.1_supplement.577.9

DOI
10.1096/fasebj.23.1_supplement.577.9
Journal article

Metoprolol represses PGC1alpha-mediated carnitine palmitoyltransferase-1B expression in the diabetic heart.

Sharma, V., Dhillon, P., Parsons, H., Allard, M. F., & McNeill, J. H. (2009). Metoprolol represses PGC1alpha-mediated carnitine palmitoyltransferase-1B expression in the diabetic heart.. European journal of pharmacology, 607(1-3), 156-166. doi:10.1016/j.ejphar.2009.02.016

DOI
10.1016/j.ejphar.2009.02.016
Journal article

2008

Metoprolol increases the expression of beta(3)-adrenoceptors in the diabetic heart: effects on nitric oxide signaling and forkhead transcription factor-3.

Sharma, V., Parsons, H., Allard, M. F., & McNeill, J. H. (2008). Metoprolol increases the expression of beta(3)-adrenoceptors in the diabetic heart: effects on nitric oxide signaling and forkhead transcription factor-3.. European journal of pharmacology, 595(1-3), 44-51. doi:10.1016/j.ejphar.2008.07.042

DOI
10.1016/j.ejphar.2008.07.042
Journal article

Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms.

Saeedi, R., Parsons, H. L., Wambolt, R. B., Paulson, K., Sharma, V., Dyck, J. R. B., . . . Allard, M. F. (2008). Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms.. American journal of physiology. Heart and circulatory physiology, 294(6), H2497-H2506. doi:10.1152/ajpheart.00873.2007

DOI
10.1152/ajpheart.00873.2007
Journal article

Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat.

Sharma, V., Dhillon, P., Wambolt, R., Parsons, H., Brownsey, R., Allard, M. F., & McNeill, J. H. (2008). Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat.. American journal of physiology. Heart and circulatory physiology, 294(4), H1609-H1620. doi:10.1152/ajpheart.00949.2007

DOI
10.1152/ajpheart.00949.2007
Journal article

Phosphorylation of carnitine palmitoyltransferase‐1 in heart mitochondria

Sharma, V., Parsons, H., Allard, M. F., & McNeill, J. H. (2008). Phosphorylation of carnitine palmitoyltransferase‐1 in heart mitochondria. The FASEB Journal, 22(S1). doi:10.1096/fasebj.22.1_supplement.1129.20

DOI
10.1096/fasebj.22.1_supplement.1129.20
Journal article

2007

An appraisal of trauma in the elderly.

Sharma, O. P., Oswanski, M. F., Sharma, V., Stringfellow, K., & Raj, S. S. (2007). An appraisal of trauma in the elderly.. The American surgeon, 73(4), 354-358.

Journal article

AMPK control of myocardial fatty acid metabolism fluctuates with the intensity of insulin-deficient diabetes.

Kewalramani, G., An, D., Kim, M. S., Ghosh, S., Qi, D., Abrahani, A., . . . Rodrigues, B. (2007). AMPK control of myocardial fatty acid metabolism fluctuates with the intensity of insulin-deficient diabetes.. Journal of molecular and cellular cardiology, 42(2), 333-342. doi:10.1016/j.yjmcc.2006.11.010

DOI
10.1016/j.yjmcc.2006.11.010
Journal article

Modulation of CPT‐1 activity and sensitivity by metoprolol

SHARMA, V., Wambolt, R., Parsons, H., Allard, M. F., & McNeill, J. H. (2007). Modulation of CPT‐1 activity and sensitivity by metoprolol. The FASEB Journal, 21(6). doi:10.1096/fasebj.21.6.a801-b

DOI
10.1096/fasebj.21.6.a801-b
Journal article

2006

N-acetylcysteine attenuates TNF-alpha-induced human vascular endothelial cell apoptosis and restores eNOS expression.

Xia, Z., Liu, M., Wu, Y., Sharma, V., Luo, T., Ouyang, J., & McNeill, J. H. (2006). N-acetylcysteine attenuates TNF-alpha-induced human vascular endothelial cell apoptosis and restores eNOS expression.. European journal of pharmacology, 550(1-3), 134-142. doi:10.1016/j.ejphar.2006.08.044

DOI
10.1016/j.ejphar.2006.08.044
Journal article

The Metabolic Syndrome: Revisiting the Concept, the Diagnosis and the Treatment (Part-II)

Sharma, V., & McNeill, J. H. (Eds.) (2006). The Metabolic Syndrome: Revisiting the Concept, the Diagnosis and the Treatment (Part-II) (Vol. 4).

Edited special journal issue

The etiology of hypertension in the metabolic syndrome part four: the systemic perspective--the role of the neuroendocrine and immune systems, and the challenge of integration.

Sharma, V., & McNeill, J. H. (2006). The etiology of hypertension in the metabolic syndrome part four: the systemic perspective--the role of the neuroendocrine and immune systems, and the challenge of integration.. Current vascular pharmacology, 4(4), 349-381. doi:10.2174/157016106778521599

DOI
10.2174/157016106778521599
Journal article

The etiology of hypertension in the metabolic syndrome part one: an introduction to the history, the concept and the models.

Sharma, V., & McNeill, J. H. (2006). The etiology of hypertension in the metabolic syndrome part one: an introduction to the history, the concept and the models.. Current vascular pharmacology, 4(4), 293-304. doi:10.2174/157016106778521616

DOI
10.2174/157016106778521616
Journal article

The etiology of hypertension in the metabolic syndrome part three: the regulation and dysregulation of blood pressure.

Sharma, V., & McNeill, J. H. (2006). The etiology of hypertension in the metabolic syndrome part three: the regulation and dysregulation of blood pressure.. Current vascular pharmacology, 4(4), 321-348. doi:10.2174/157016106778521643

DOI
10.2174/157016106778521643
Journal article

The etiology of hypertension in the metabolic syndrome part two: the gene-environment interaction.

Sharma, V., & McNeill, J. H. (2006). The etiology of hypertension in the metabolic syndrome part two: the gene-environment interaction.. Current vascular pharmacology, 4(4), 305-320. doi:10.2174/157016106778521661

DOI
10.2174/157016106778521661
Journal article

Metabolic Syndrome: Revisiting the Concept, the Diagnosis and the Treatment (Part-I)

Sharma, V., & McNeill, J. H. (Eds.) (2006). Metabolic Syndrome: Revisiting the Concept, the Diagnosis and the Treatment (Part-I) (Vol. 4).

Edited special journal issue

Diabetic cardiomyopathy: where are we 40 years later?

Sharma, V., & McNeill, J. H. (2006). Diabetic cardiomyopathy: where are we 40 years later?. The Canadian journal of cardiology, 22(4), 305-308. doi:10.1016/s0828-282x(06)70914-x

DOI
10.1016/s0828-282x(06)70914-x
Journal article

2005

N-acetylcysteine dose-dependently reduces TNF-α cellular toxicity

Ouyang, J., Xia, Z., Luo, T., Liu, M., Sharma, V., & McNeill, J. H. (2005). N-acetylcysteine dose-dependently reduces TNF-α cellular toxicity. Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 52(S1), A212. doi:10.1007/bf03023250

DOI
10.1007/bf03023250
Journal article

Vanadium complexes with mixed O,S anionic ligands derived from maltol: synthesis, characterization, and biological studies.

Monga, V., Thompson, K. H., Yuen, V. G., Sharma, V., Patrick, B. O., McNeill, J. H., & Orvig, C. (2005). Vanadium complexes with mixed O,S anionic ligands derived from maltol: synthesis, characterization, and biological studies.. Inorganic chemistry, 44(8), 2678-2688. doi:10.1021/ic0486926

DOI
10.1021/ic0486926
Journal article

The emerging roles of leptin and ghrelin in cardiovascular physiology and pathophysiology.

Sharma, V., & McNeill, J. H. (2005). The emerging roles of leptin and ghrelin in cardiovascular physiology and pathophysiology.. Current vascular pharmacology, 3(2), 169-180. doi:10.2174/1570161053586868

DOI
10.2174/1570161053586868
Journal article

2002

Vanadium increases GLUT4 in diabetic rat skeletal muscle.

Mohammad, A., Sharma, V., & McNeill, J. H. (2002). Vanadium increases GLUT4 in diabetic rat skeletal muscle.. Molecular and cellular biochemistry, 233(1-2), 139-143. doi:10.1023/a:1015558328757

DOI
10.1023/a:1015558328757
Journal article